Wegovy 5mg: understanding this dose and what it means for your treatment

You searched for 5mg (here is what is likely going on

Picture this: you have just started Wegovy, or you are considering it, and you have come across the figure "5mg" somewhere) a forum, a friend's experience, maybe a comparison chart. It is an honest point of confusion. The number 5mg is real and meaningful in the world of weight-loss injections, but it belongs to a different medicine entirely. Mounjaro (tirzepatide) uses a 5mg pen as one of its dose steps. Wegovy's schedule works on a completely different scale.

The full licensed Wegovy titration in the UK, as set out in the medicine's SmPC, runs: 0.25mg, then 0.5mg, then 1mg, then 1.7mg, then 2.4mg as the standard maintenance dose. Since January 2026, the MHRA has also approved 7.2mg as the highest available dose for adults with obesity, subsequently granting approval for a dedicated single-dose 7.2mg pen in April 2026. No 5mg step exists in that sequence. If you have been prescribed what feels like a "middle" Wegovy dose, you are almost certainly on 1mg or 1.7mg, both of which sit comfortably in the middle of the titration ladder.

It is worth reading about the full Wegovy dose progression if you want to see exactly where each pen sits and what it is designed to achieve. The short version: the lower doses settle your system; the higher doses do the heavier lifting on appetite and weight.

Why the 5mg figure comes up (and the Mounjaro comparison

The overlap happens because tirzepatide and semaglutide are often discussed side by side, and rightly so) they are both injectable weight-loss medicines licensed in the UK, taken once a week, and recommended by NICE for adults with a qualifying BMI and at least one weight-related condition. The difference is that tirzepatide is a dual GIP and GLP-1 receptor agonist, while semaglutide targets the GLP-1 pathway only. Their dose numbers do not translate across to each other.

If you have seen references to semaglutide 5mg, these typically refer to a strength used in the Ozempic diabetes pen rather than Wegovy for weight loss, another distinction worth keeping clear. Ozempic is also semaglutide, but it is licensed for type 2 diabetes, not weight management, and it should not be used interchangeably with Wegovy. The MHRA is direct on this point.

For a broader look at how semaglutide doses compare and where the 5mg figure appears in the wider semaglutide family, the semaglutide 5mg pen dosage page walks through each product and licence clearly. The NHS also provides accessible guidance on semaglutide through its medicines pages, which is a useful companion read alongside your Patient Information Leaflet.

How Wegovy titration actually works, and why the pace matters

Starting Wegovy means starting low: 0.25mg for the first four weeks. That dose is not doing heavy work on your weight. Its job is to let your body adjust to semaglutide before the dose climbs. Nausea and other gastrointestinal effects tend to be at their most noticeable in the early weeks or after a step up, and the gradual titration is specifically designed to keep those effects manageable.

From 0.25mg, the schedule moves to 0.5mg, then 1mg, then 1.7mg, and then 2.4mg, each step typically separated by around four weeks. Your prescriber may slow that pace if side effects are significant, or keep it if you are tolerating the medicine well. The decision sits with them, not with a chart. That is why a review before each dose change matters: a deeper look at how many doses are in each pen can also help you plan practically, one pen covers four weekly injections at a single dose strength.

If you are wondering what private treatment costs across the dose schedule, our Wegovy price comparison sets out what to look for and what questions to ask any provider. For the medicine itself, the Wegovy overview page covers the full picture: how it works, what the trial evidence shows, and what to expect from treatment.

What to do if your dose feels unclear

If you are mid-treatment and genuinely unsure which dose you are on, your pen itself is the clearest guide, the strength is printed on the label, and the Patient Information Leaflet covers what each step means. The NHS guidance on semaglutide is worth bookmarking as a reliable plain-language reference.

A question our prescribers hear fairly often: "Should I be on a higher dose by now?" The honest answer is that the right pace depends on how you are tolerating the medicine, not on a calendar. Rushing titration to hit a number faster than your body is ready for usually means more side effects and sometimes a step back. Patience in the first few months tends to pay off later.

If you are still in the research stage (thinking about whether Wegovy is right for you before committing to treatment) our weight-loss treatment overview sets out the options side by side. And if questions about the process itself are holding you back, the frequently asked questions page covers most of what people want to know before their first consultation. When you are ready, start your free consultation and a GPhC-registered prescriber will review your information the same day.